ACLX Arcellx | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.42
-0.5% | $81.00 | Buy ➝ Buy | |
ADEA Adeia | Reiterated by | BWS Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.03
+10.4% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
ADUS Addus HomeCare | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.59
+6.8% | $115.00 | Overweight ➝ Overweight | |
AGEN Agenus | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.01
-7.3% | $40.00 | Buy ➝ Buy | |
ALTO Alto Ingredients | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.76
-9.7% | $5.50 | Buy ➝ Buy | |
AMG Affiliated Managers Group | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.56
-1.1% | $190.00 ➝ $190.00 | Outperform ➝ Outperform | |
|
AMR Alpha Metallurgical Resources | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $304.57
+2.7% | | Hold | |
AVNS Avanos Medical | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.54
-1.0% | | Market Perform | |
AXON Axon Enterprise | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $312.73
-4.6% | $400.00 | Buy ➝ Buy | |
AXON Axon Enterprise | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $312.73
-4.6% | $375.00 | Market Outperform ➝ Market Outperform | |
AXSM Axsome Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94
+1.3% | $190.00 | Buy ➝ Buy | |
BCRX BioCryst Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.26
-0.2% | $12.00 | Buy ➝ Buy | |
BCRX BioCryst Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.26
-0.2% | $30.00 | Buy ➝ Buy | |
BOWL Bowlero | Reiterated by | CJS Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27
+0.6% | | Market Outperform ➝ Market Perform | |
BRBR BellRing Brands | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.44
+2.2% | $53.00 | Equal Weight ➝ Equal Weight | |
BRBR BellRing Brands | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.44
+2.2% | $62.00 | Buy ➝ Buy | |
CART Maplebear | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.52
+2.7% | | Hold | |
CART Maplebear | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.52
+2.7% | | Hold | |
CGNX Cognex | Reiterated by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.90
+3.2% | $47.00 ➝ $50.00 | Buy ➝ Buy | |
CLDX Celldex Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.21
+1.3% | $80.00 | Buy ➝ Buy | |
CLSK CleanSpark | Reiterated by | Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.54
-5.1% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
CMPO CompoSecure | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.53
+3.9% | $15.00 | Buy ➝ Buy | |
CMPR Cimpress | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.24
+1.0% | $113.00 ➝ $113.00 | Outperform ➝ Outperform | |
CRNT Ceragon Networks | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.77
-12.1% | $5.25 | Buy ➝ Buy | |
CTSO Cytosorbents | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Lee
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.93
+0.2% | $1.00 | Neutral ➝ Neutral | |
DAWN Day One Biopharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.08
+2.9% | $33.00 | Buy ➝ Buy | |
DAWN Day One Biopharmaceuticals | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.08
+2.9% | $33.00 | Outperform | |
DDOG Datadog | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.40
-11.5% | $165.00 | Buy ➝ Buy | |
DIS Walt Disney | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.39
-9.5% | $145.00 | Buy ➝ Buy | |
EOG EOG Resources | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.26
-0.2% | | Hold | |
ESPR Esperion Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.37
+11.8% | $8.00 | Buy ➝ Buy | |
FHTX Foghorn Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.63
-3.4% | $20.00 | Buy ➝ Buy | |
FIS Fidelity National Information Services | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31
+5.5% | $90.00 | Overweight ➝ Overweight | |
FIS Fidelity National Information Services | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31
+5.5% | | Outperform | |
FN Fabrinet | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $209.31
+10.8% | $220.00 | Buy ➝ Buy | |
GHRS GH Research | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.08
+3.3% | $40.00 | Buy ➝ Buy | |
GPRE Green Plains | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.28
-3.1% | $24.00 | Equal Weight ➝ Equal Weight | |
GROV Grove Collaborative | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.65
+2.5% | $3.00 ➝ $3.00 | Outperform ➝ Outperform | |
HALO Halozyme Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.21
+0.9% | $50.00 | Buy ➝ Buy | |
HD Home Depot | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.69
-0.5% | $360.00 ➝ $360.00 | Market Perform ➝ Market Perform | |
Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (Ad) Trump Asset Seizures Threat A Warning For 401K Owners? Request Your FREE WEALTH PROTECTION GUIDE |
HUT Hut 8 | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.19
-7.5% | $12.00 | Buy ➝ Buy | |
IAS Integral Ad Science | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.90
-0.7% | | Hold | |
ILMN Illumina | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.82
-5.2% | $170.00 | Overweight ➝ Overweight | |
ITCI Intra-Cellular Therapies | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.21
+0.3% | $90.00 | Buy | |
JJSF J&J Snack Foods | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $160.47
+16.4% | $195.00 | Buy ➝ Buy | |
KIDS OrthoPediatrics | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.70
+3.3% | $50.00 | Market Outperform ➝ Market Outperform | |
LBPH Longboard Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.05
+7.0% | $60.00 | Buy ➝ Buy | |
LCID Lucid Group | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.62
-14.1% | | Hold | |
LYEL Lyell Immunopharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.54
| $6.00 | Buy ➝ Buy | |
MCHP Microchip Technology | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06
-1.8% | $80.00 ➝ $90.00 | Neutral ➝ Neutral | |
MODN Model N | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.77
+0.3% | | Hold | |
MYPS PLAYSTUDIOS | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.42
+3.9% | $5.00 | Buy ➝ Buy | |
NCMI National CineMedia | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.61
-4.6% | $6.00 | Speculative Buy ➝ Speculative Buy | |
NCMI National CineMedia | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.61
-4.6% | $5.50 | Neutral | |
NOW ServiceNow | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33
-1.8% | | Outperform | |
NOW ServiceNow | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33
-1.8% | $825.00 | Market Outperform ➝ Market Outperform | |
NOW ServiceNow | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33
-1.8% | $900.00 | Buy ➝ Buy | |
OMGA Omega Therapeutics | Reiterated by | Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.16
-5.3% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
ONON ON | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.01
-0.1% | $37.00 ➝ $37.00 | Outperform ➝ Outperform | |
PLRX Pliant Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $38.00 | Buy ➝ Buy | |
PLRX Pliant Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $36.00 | Buy ➝ Buy | |
PLTR Palantir Technologies | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40
-15.1% | | Underperform | |
PNTG The Pennant Group | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.91
-3.1% | $23.00 | Overweight ➝ Overweight | |
PRAA PRA Group | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.04
-1.1% | $33.00 | Market Outperform ➝ Market Outperform | |
PRFT Perficient | Reiterated by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28
+0.0% | $76.00 | Buy ➝ Hold | |
PRFT Perficient | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28
+0.0% | | Outperform ➝ Market Perform | |
PRFT Perficient | Reiterated by | Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28
+0.0% | | Buy ➝ Neutral | |
PRME Prime Medicine | Reiterated by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57
+3.1% | $23.00 ➝ $15.00 | Buy ➝ Buy | |
PTLO Portillo's | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.61
-12.5% | $20.00 | Overweight ➝ Overweight | |
PTON Peloton Interactive | Reiterated by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.09
+15.5% | | Outperform | |
PYXS Pyxis Oncology | Reiterated by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.38
+1.6% | $10.00 | Buy ➝ Buy | |
RCKT Rocket Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.36
+0.7% | $53.00 | Buy ➝ Buy | |
ROOT Root | Reiterated by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.97
+11.2% | $70.00 ➝ $80.00 | Outperform ➝ Outperform | |
SAFE Safehold | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.80
+3.7% | $35.00 | Market Outperform ➝ Market Outperform | |
SGH SMART Global | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.53
-0.3% | $27.00 | Buy ➝ Buy | |
SHOP Shopify | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.05
-0.4% | | Hold | |
SIBN SI-BONE | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.68
+8.3% | $27.00 | Buy ➝ Buy | |
SIBN SI-BONE | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.68
+8.3% | $32.00 | Market Outperform ➝ Market Outperform | |
SNV Synovus Financial | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.38
-0.8% | $38.00 | Equal Weight ➝ Equal Weight | |
SRRK Scholar Rock | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.69
-2.5% | $23.00 | Outperform | |
STOK Stoke Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.94
+0.6% | $35.00 | Buy ➝ Buy | |
SYM Symbotic | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.50
+10.9% | $54.00 | Buy ➝ Buy | |
TDUP ThredUp | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.95
+4.8% | $5.00 | Buy ➝ Buy | |
TTI TETRA Technologies | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.89
+0.8% | $8.00 | Buy ➝ Buy | |
TVTX Travere Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.75
+3.1% | $19.00 | Buy ➝ Buy | |
UPLD Upland Software | Reiterated by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.36
+5.3% | $3.00 ➝ $2.50 | Sell ➝ Sell | |
VIR Vir Biotechnology | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.93
-2.8% | $110.00 | Buy ➝ Buy | |
VMEO Vimeo | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.92
+3.2% | $4.00 ➝ $4.50 | Neutral ➝ Neutral | |
VRTX Vertex Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.24
+1.9% | | Hold | |
VRTX Vertex Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.24
+1.9% | $462.00 | Buy ➝ Buy | |
The Sneaky IRS Tax Law that's Sweeping the U.S. (Ad) In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings. Request your info kit on gold now |
ZETA Zeta Global | Reiterated by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38
+18.3% | $21.00 | Buy ➝ Buy | |
ZYME Zymeworks | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.12
+0.7% | $10.00 | Neutral ➝ Neutral | |
